WBWei Bi

Wei Bi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wei Bi has a total of 91 co-authors. Here are the top co-authors by number of shared publications:

  • Zhaohao Zeng

    Jinan University First Affiliated Hospital

    5 shared publications
  • Lihong Zhu

    School of Medicine, Jinan University

    3 shared publications
  • Lu Wang

    Jinan University First Affiliated Hospital

    3 shared publications
  • Rixin Luo

    Department of Neurology The First Affiliated Hospital, Jinan University Guangzhou People's Republic of China

    3 shared publications
  • Ao Pan

    The First Affiliated Hospital of Jinan University

    2 shared publications
  • Jiawei Zhang

    Department of Pathophysiology Key Laboratory of State Administration of Traditional Chinese Medicine of the People's Republic of China, School of Medicine, Jinan University Guangzhou People's Republic of China

    2 shared publications

Latest Publications

  • GPR75 mediates hyperuricemia-induced endothelial inflammatory injury via a HOTAIR/miR-141-3p regulatory network

    by Jiawu Fu, Junbing He, Keshen Li, Manting Zhang, Jiekai Li, Yuchun Liu, Yusen Chen, Wei Bi

  • Open Access

    Development and validation of a prediction model for severe disturbance of consciousness in patients with non-traumatic intracranial hemorrhage using albumin-corrected anion gap: A retrospective cohort study

    by Jianping Liu, Ao Pan, Qianwen Chen, Lihong Zhu, Jun Lyu, Wei Bi

    Objective: The aims of this study were to develop and validate a prediction model for severe disturbance of consciousness (SDOC) occurring within 30 days of intensive care unit (ICU) admission in patients with non-traumatic intracranial hemorrhage (NTICH), and to compare and validate the predictive value of anion gap (AG), serum albumin, and albumin-corrected anion gap (ACAG) for SDOC in this population. Methods: This study is a retrospective cohort study. It included a total of 873 patients with NTICH from the Medical Information Mart for Intensive Care (MIMIC-IV) database. These patients were randomly allocated in a 7:3 ratio to a training cohort (n = 611) and a validation cohort (n = 262). Variables selected from the Least Absolute Shrinkage and Selection Operator (LASSO) regression were subsequently entered into a multivariable logistic regression analysis, with those demonstrating a P-value< 0.05 incorporated into the final model to develop a dynamic nomogram. The discriminative ability of the model was evaluated by receiver operating characteristic (ROC) curves and calculating the area under the curve (AUC). Model performance was assessed using calibration curves and the Hosmer-Lemeshow goodness-of-fit test (HL test). Furthermore, decision curve analysis (DCA) was employed to evaluate the net clinical benefit of the model. Results: We developed a 14-variable prediction model for the occurrence of SDOC within 30 days of NTICH patients’ ICU admission. The prediction model demonstrated satisfactory discriminative ability in the validation cohort, with an AUC of 0.870. Notably, ACAG showed superior predictive performance compared to AG and serum albumin alone. The constructed nomogram exhibited good calibration performance. DCA further confirmed the clinical utility of this predictive model. Conclusions: This study developed a prediction model for estimating the risk of SDOC within 30 days of admission in patients with NTICH. Furthermore, ACAG demonstrated significant importance in patients who developed SDOC.

  • Open Access

    Association between environmental phthalates exposure and gut microbiota and metabolome in dementia with Lewy bodies

    by Zhe Deng, Ling Li, Zhen Jing, Xi Luo, Fang Yu, Wenshuang Zeng, Wei Bi, Jing Zou


  • Open Access

    High-throughput discovery of highly selective reversible hMAO-B inhibitors based on at-line nanofractionation

    by Yu Fan, Jincai Wang, Jingyi Jian, Yalei Wen, Jiahao Li, Hao Tian, Jacques Crommen, Wei Bi, Tingting Zhang, Zhengjin Jiang


  • Open Access

    Exploring the research landscape of COVID-19-induced olfactory dysfunction: A bibliometric study

    by Zhirong Yang, Yukun Ma, Wei Bi, Jingqian Tang

    Since the outbreak of COVID-19, olfactory dysfunction (OD) has become an important and persistent legacy problem that seriously affects the quality of life. The purpose of this paper is to quantitatively analyze and visualize the current research status and development trend of COVID-19 related OD by using VOSviewer software. Based on the Web of Science database, a total of 1,592 relevant documents were retrieved in January 2023, with publication time spanning from 2020 to 2023. The bibliometric analysis revealed that the most influential research results in the field of COVID-19 related OD were concentrated in journals of related disciplines such as otorhinolaryngology, medicine, general and internal, virology, neurosciences, etc. The knowledge base of the research is mainly formed in two fields: COVID-19 clinical research and OD specialized research. The research hotspots are mainly concentrated in six directions: COVID-19, long COVID, smell, anosmia, OD, and recovery. Based on the results of the bibliometric analysis, the temporal trends of COVID-19 related OD studies were visually revealed, and relevant suggestions for future research were proposed.


  • Open Access

    Cerebellar Hemorrhage Secondary to CLIPPERS: a Case Report

    by Yanmei Cen, Lu Wang, Zhaohao Zeng, Yezi Xu, Rui Cao, Huijuan Yu, Wei Bi

    Cerebral hemorrhage is an extremely rare complication of CLIPPERS. We report a patient who developed CLIPPERS in his 50s and was responding to glucocorticoid therapy developed cerebellar space-occupying hemorrhage with high glucose metabolism in bilateral cerebellar hemispheres during hospitalization.

  • Open Access

    Targeted brain delivery of RVG29‐modified rifampicin‐loaded nanoparticles for Alzheimer's disease treatment and diagnosis

    by Ruiyi Zhou, Lihong Zhu, Zhaohao Zeng, Rixin Luo, Jiawei Zhang, Rui Guo, Lei Zhang, Qunying Zhang, Wei Bi

    Alzheimer's disease (AD) is an aging‐related neurodegenerative disease. The main pathological features of AD are β‐amyloid protein (Aβ) deposition and tau protein hyperphosphorylation. Currently, there are no effective drugs for the etiological treatment of AD. Rifampicin (RIF) is a semi‐synthetic broad‐spectrum antibiotic with anti‐β‐amyloid deposition, anti‐inflammatory, anti‐apoptosis, and neuroprotective effects, but its application in AD treatment has been limited for its strong hydrophobicity, high toxicity, short half‐life, low bioavailability, and blood–brain barrier hindrance. We designed a novel brain‐targeted and MRI‐characteristic nanomedicine via loading rabies virus protein 29 (RVG29), rifampicin, and Gd on poly (l‐lactide) nanoparticles (RIF@PLA‐PEG‐Gd/Mal‐RVG29). The cytotoxicity assay demonstrated that RIF@PLA‐PEG‐Gd/Mal‐RVG29 had favorable biocompatibility and security. Fluorescence imaging in vivo showed that PLA‐PEG‐Gd/Mal‐RVG29 could deliver rifampicin into the brain by enhancing cellular uptake and brain targeting performance, leading to improvement of the bioavailability of rifampicin. In in vivo study, RIF@PLA‐PEG‐Gd/Mal‐RVG29 improved the spatial learning and memory capability of APP/PS1 mice in the Morris water maze, as compared to rifampicin. Immunofluorescence, TEM, immunoblotting, and H&E staining revealed that RIF@PLA‐PEG‐Gd/Mal‐RVG29 reduced Aβ deposition in hippocampal and cortex of APP/PS1 mice, improved the damage of synaptic ultrastructure, increased the expression level of PSD95 and SYP, as well as reduced the necrosis of neurons. These findings suggest that RIF@PLA‐PEG‐Gd/Mal‐RVG29 may be an effective strategy for the treatment of AD.


  • Open Access

    Warfarin-related epidural hematoma: a case report

    by Xiaoting Li, Zhaohao Zeng, Ying Yang, Weilong Ding, Lu Wang, Yezi Xu, Wei Yang, Wei Bi

    Spinal epidural hematomas are rare, with trauma being the most common cause. Spinal epidural hematomas caused by coagulation dysfunction are even rarer; however, long-term warfarin therapy increases the risk. The clinical manifestations of spinal epidural hematoma are neurological deficits below the corresponding spinal cord segment level. Magnetic resonance imaging (MRI) is the preferred method for diagnosis, and the main treatment for epidural hematoma with typical symptoms is urgent decompression of the lumbar spine. We describe an almost 80-year-old female patient who received long-term oral warfarin therapy for atrial fibrillation. She developed sudden onset waist pain, and 2 days later, she developed pain and weakness in both lower limbs. Computed tomography (CT) of the thoracolumbar spine showed no obvious hematoma. Eight days after admission, contrast-enhanced CT of the thoracolumbar spine showed intraspinal hematomas at T5–T8 and T12–L2 levels. We performed T3–T7 laminectomy, T5–T8 hematoma removal, and spinal dural repair. The clinical symptoms did not improve significantly, postoperatively. The low incidence of spinal epidural hematoma after anticoagulation treatment means this condition is not recognized timely, and it is misdiagnosed easily. Clinicians should consider this condition when patients treated with anticoagulants have neurological deficits below a spinal segmental plane.


  • Open Access

    Dl‑butylphthalide inhibits rotenone‑induced oxidative stress in microglia via regulation of the Keap1/Nrf2/HO‑1 signaling pathway

    by Rixin Luo, Lihong Zhu, Zhaohao Zeng, Ruiyi Zhou, Jiawei Zhang, Shu Xiao, Wei Bi

    Activated microglia are a source of superoxide which often increases oxidative stress in the brain microenvironment, increase production of reactive oxygen species (ROS) and directly or indirectly lead to dopaminergic neuronal death in the substantia nigra. Thus superoxide contributes to the pathogenesis of Parkinson's disease (PD). Evidence suggests that mitochondria are the main source of ROS, which cause oxidative stress in cells. Levels of ROS are thus associated with the function of the mitochondrial complex. Therefore, protecting the mitochondrial function of microglia is important for the treatment of PD. Dl‑butylphthalide (NBP), a compound isolated from Chinese celery seeds, has been approved by the China Food and Drug Administration for the treatment of acute ischemic stroke. Recently, NBP demonstrated therapeutic potential for PD. However, the mechanism underlying its neuroprotective effect remains unclear. The present study aimed to investigate the effect of NBP on rotenone‑induced oxidative stress in microglia and its underlying mechanisms. The results demonstrated that NBP treatment significantly increased mitochondrial membrane potential and decreased ROS level in rotenone‑induced microglia. Western blot analysis showed that NBP treatment promoted entry of nuclear respiratory factor‑2 (Nrf2) into the nucleus, increased heme oxygenase‑1 (HO‑1) expression and decreased the level of the Nrf2 inhibitory protein, Kelch‑like ECH‑associated protein 1. Overall, the findings indicated that NBP inhibited rotenone‑induced microglial oxidative stress via the Keap1/Nrf2/HO‑1 pathway, suggesting that NBP may serve as a novel agent for the treatment of PD.